Læknablaðið - 01.01.2022, Blaðsíða 28

28 L ÆKNABL AÐIÐ 2022/108
Heimildir
1. Tryggvadóttir L, EJÓoHB. Krabbameinsskrá Íslands hjá Krabbameinsfélagi Íslands mars
2021
2. Harðardóttir H, Valdimarsdóttir UA, Guðbjartsson T, et al. Greiningarferli lungnakrabba-
meins á Landspítala: sjúklingamiðuð nálgun. Læknablaðið 2017; 103: 171-7.
3. Zhang Z, Zhu D, Cui B, et al. Association between particulate matter air pollution and
lung cancer. Thorax 2020; 75: 85-7.
4. Talnabrunnur, fréttabréf landlæknis um heilbrigðisupplýsingar. landlaeknir.is/servlet/file/
store93/item39682/Talnabrunnur_Mars_2020.pdf - maí 2021.
5. Danckert B FJ, Engholm G, Hansen HL, et al. NORDCAN. Version 8.2 (26.03.2019).
6. Guðbjartsson T, Smáradóttir A, Skúladóttir H, et al. Lungnakrabbamein - yfirlitsgrein.
Læknablaðið 2008; 94: 297-311.
7. Aberle DR, Adams AM, Berg CD, al. Reduced lung-cancer mortality with low-dose
computed tomographic screening. N Engl J Med 2011; 365: 395-409.
8. Kaneko M, Kusumoto M, Kobayashi T, et al. Computed tomography screening for lung
carcinoma in Japan. Cancer 2000; 89 (11 Suppl): 2485-8.
9. Henschke CI, Yankelevitz DF, Libby DM, et al. Survival of patients with stage I lung cancer
detected on CT screening. N Engl J Med 2006; 355: 1763-71.
10. Field JK, Marcus MW, Oudkerk M. Risk assessment in relation to the detection of small
pulmonary nodules. Transl Lung Cancer Res 2017; 6: 35-41.
11. de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced Lung-Cancer Mortality with
Volume CT Screening in a Randomized Trial. N Engl J Med 2020; 382: 503-13.
12. Chad-Friedman E, Coleman S, Traeger LN, et al. Psychological distress associated with
cancer screening: A systematic review. Cancer 2017; 123: 3882-94.
13. Katki HA, Kovalchik SA, Berg CD, et al. Development and Validation of Risk Models to
Select Ever-Smokers for CT Lung Cancer Screening. JAMA 2016; 315: 2300-11.
14. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004;
83: 1-1438.
15. Pedersen JH, Sørensen JB, Saghir Z, et al. Implementation of lung cancer CT screening in
the Nordic countries. Acta Oncol 2017; 56: 1249-57.
16. Jonsson S, Thorsteinsdottir U, Gudbjartsson DF, et al. Familial risk of lung carcinoma in
the Icelandic population. JAMA 2004; 292: 2977-83.
17. Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization
Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since
the 2004 Classification. J Thorac Oncol 2015; 10: 1243-60.
18. Comprehensive molecular profiling of lung adenocarcinoma. Nature 2014; 511: 543-50.
19. Annema JT, Versteegh MI, Veseliç M, et al. Endoscopic ultrasound-guided fine-needle
aspiration in the diagnosis and staging of lung cancer and its impact on surgical staging. J
Clin Oncol 2005; 23: 8357-61.
20. Dong Z, Li H, Zhou J, et al. The value of cell block based on fine needle aspiration for lung
cancer diagnosis. J Thorac Dis 2017; 9: 2375-82.
21. Hirsch FR, Scagliotti GV, Mulshine JL, et al. Lung cancer: current therapies and new tar-
geted treatments. Lancet 2017; 389: 299-311.
22. Zugazagoitia J, Molina-Pinelo S, Lopez-Rios F, et al. Biological therapies in nonsmall cell
lung cancer. Eur Respir J 2017; 49: 1601520.
23. Asao T, Takahashi F, Takahashi K. Resistance to molecularly targeted therapy in non small-
cell lung cancer. Respir Investig 2019; 57: 20-6.
24. Ancevski Hunter K, Socinski MA, Villaruz LC. PD-L1 Testing in Guiding Patient Selection
for PD-1/PD-L1 Inhibitor Therapy in Lung Cancer. Mol Diagn Ther 2018; 22: 1-10.
25. NICE guidelines on Lung cancer (NG122): diagnosis and management, march 2019.
26. Orrason AW, Sigurdsson MI, Baldvinsson K, et al. T. Incidental detection by computed
tomography is an independent prognostic factor for survival in patients operated for nons-
mall cell lung carcinoma. ERJ Open Res 2017; 3: 00106-2016.
27. Jeong YJ, Yi CA, Lee KS. Solitary pulmonary nodules: detection, characterization, and gui-
dance for further diagnostic workup and treatment. AJR Am J Roentgenol 2007; 188: 57-68.
28. MacMahon H, Naidich DP, Goo JM, et al. Guidelines for Management of Incidental
Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017. Radiology
2017; 284: 228-43.
29. Wahbah M, Boroumand N, Castro C, et al. Changing trends in the distribution of the
histologic types of lung cancer: a review of 4,439 cases. Ann Diagn Pathol 2007; 11: 89-96.
30. Guðmundsson G, Jónsson HM. Hnútar í lungum og eftirfylgni þeirra. Læknablaðið 2020;
106: 214.
31. Groheux D, Quere G, Blanc E, et al. FDG PET-CT for solitary pulmonary nodule and lung
cancer: Literature review. Diagn Interv Imaging 2016; 97: 1003-17.
32. Ardila D, Kiraly AP, Bharadwaj S, et al. End-to-end lung cancer screening with three -
dimensional deep learning on low-dose chest computed tomography. Nat Med 2019; 25:
954-61.
33. AbdulJabbar K, Raza SEA, Rosenthal R, et al. Geospatial immune variability illuminates
differential evolution of lung adenocarcinoma. Nat Med 2020; 26: 1054-62.
34. Goldstraw P, Chansky K, Crowley J, et al. The IASLC Lung Cancer Staging Project:
Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition
of the TNM Classification for Lung Cancer. J Thorac Oncol 2016; 11: 39-51.
35. Simon GR, Turrisi A. Management of small cell lung cancer: ACCP evidence-based clinical
practice guidelines (2nd edition). Chest 2007; 132 (3 Suppl): 324s-39s.
36. Elliott JA, Osterlind K, Hirsch FR, et al. Metastatic patterns in small-cell lung cancer:
correlation of autopsy findings with clinical parameters in 537 patients. J Clin Oncol 1987;
5: 246-54.
37. Früh M, De Ruysscher D, Popat S, et al. Small-cell lung cancer (SCLC): ESMO Clinical
Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24 (Suppl 6):
vi99-105.
38. Rami-Porta R, Call S, Dooms C, et al. Lung cancer staging: a concise update. Eur Respir J
2018; 51: 1800190.
39. Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging non-small cell lung cancer:
Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians
evidence-based clinical practice guidelines. Chest 2013; 143 (5 Suppl): e211S-e50S.
40. Naruke T, Tsuchiya R, Kondo H, et al. Lymph node sampling in lung cancer: how should
it be done? Eur J Cardiothorac Surg 1999; 16 Suppl 1: S17-24.
41. De Leyn P, Dooms C, Kuzdzal J, et al. Revised ESTS guidelines for preoperative medi-
astinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg 2014;
45: 787-98.
42. Gregory DL, Hicks RJ, Hogg A, et al. Effect of PET/CT on management of patients with
non-small cell lung cancer: results of a prospective study with 5-year survival data. J Nucl
Med 2012; 53: 1007-15.
43. Verboom P, van Tinteren H, Hoekstra OS, et al. Cost-effectiveness of FDG-PET in staging
non-small cell lung cancer: the PLUS study. Eur J Nucl Med Mol Imaging 2003; 30: 1444-9.
44. Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis
of suspected lung cancer: summary of published evidence. Chest 2003; 123(1 Suppl): 115s-
28s.
45. Rivera MP, Mehta AC, Wahidi MM. Establishing the diagnosis of lung cancer: Diagnosis
and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-
based clinical practice guidelines. Chest 2013; 143 (5 Suppl): e142S-e65S.
46. Li H, Boiselle PM, Shepard JO, et al. Diagnostic accuracy and safety of CT-guided
percutaneous needle aspiration biopsy of the lung: comparison of small and large
pulmonary nodules. AJR Am J Roentgenol 1996; 167: 105-9.
47. Heerink WJ, de Bock GH, de Jonge GJ, et al. Complication rates of CT-guided transthoracic
lung biopsy: meta-analysis. Eur Radiol 2017; 27: 138-48.
48. Ma L, Fang Y, Zhang T, et al. Comparison in efficacy and safety of forceps biopsy for per-
ipheral lung lesions guided by endobronchial ultrasound-guided sheath (EBUS-GS) and
electromagnetic navigation bronchoscopy combined with EBUS (ENB-EBUS). Am J Transl
Res 2020; 12: 4604-11.
49. Zhang R, Ying K, Shi L, et al. Combined endobronchial and endoscopic ultrasound-guided
fine needle aspiration for mediastinal lymph node staging of lung cancer: a meta-analysis.
Eur J Cancer 2013; 49: 1860-7.
50. Detterbeck FC, Jantz MA, Wallace M, et al. Invasive mediastinal staging of lung cancer:
ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132 (3 Suppl):
202s-20s.
51. Ólafsdóttir TS, Guðmundsson G, Björnsson J, et al. Miðmætisspeglanir á Íslandi: Árangur
og ábendingar. Læknablaðið 2010; 96: 399-403.
52. Thorsteinsson H, Alexandersson A, Oskarsdottir GN, et al. Resection rate and outcome of
pulmonary resections for non-small-cell lung cancer: a nationwide study from Iceland. J
Thorac Oncol 2012; 7: 1164-9.
53. Ramnath N, Dilling TJ, Harris LJ, et al. Treatment of stage III non-small cell lung cancer:
Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians
evidence-based clinical practice guidelines. Chest 2013; 143 (5 Suppl): e314S-e40S.
54. Oskarsdottir GN, Halldorsson H, Sigurdsson MI, et al. Lobectomy for non-small cell lung
carcinoma: a nationwide study of short- and long-term survival. Acta Oncol 2017; 56: 936-
42.
55. Whitson BA, Groth SS, Maddaus MA. Surgical assessment and intraoperative
management of mediastinal lymph nodes in non-small cell lung cancer. Ann Thorac Surg
2007; 84: 1059-65.
56. Detterbeck FC, Lewis SZ, Diekemper R, et al. Executive Summary: Diagnosis and
management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based
clinical practice guidelines. Chest 2013; 143 (5 Suppl): 7s-37s.
57. Halldorsson H, Orrason AW, Oskarsdottir GN, et al. Improved long-term survival foll-
owing pulmonary resections for non-small cell lung cancer: results of a nationwide study
from Iceland. Ann Transl Med 2019; 7: 88.
58. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1
N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995; 60: 615-
22; discussion 22-3.
59. Þorsteinsson H, Jónsson S, Alfreðsson H, et al. Árangur lungnabrottnámsaðgerða við
lungnakrabbameini á Íslandi. Læknablaðið 2009; 95: 823-9.
60. Gudbjartsson T, Gyllstedt E, Pikwer A, Early surgical results after pneumonectomy for
non-small cell lung cancer are not affected by preoperative radiotherapy and chemother-
apy. Ann Thorac Surg 2008; 86: 376-82.
Allar heimildirnar eru birtar á heimasíðu blaðsins.
Y F I R L I T S G R E I N